<DOC>
	<DOCNO>NCT02405520</DOCNO>
	<brief_summary>This phase I clinical study design evaluate safety immunogenicity novel recombinant HPV type 6/11 bivalent vaccine , manufacture Xiamen Innovax Biotech CO. , LTD. , healthy volunteer age 18-55 year age enrollment . The study volunteer receive 3 different formulation novel HPV vaccine placebo administer intramuscularly accord 0-1-6 month schedule .</brief_summary>
	<brief_title>Safety Immunogenicity Study Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : 1 . Females age 18 55 year . 2 . Judged healthy eligible vaccination investigator selfreported medical history physical examination . 3 . Written inform consent obtain participant . 4 . Able comply request study . 5 . Axillary temperature high 37.0°C 6 . Nonpregnancy verify urine pregnancy test . Exclusion criterion : 1 . Pregnant breastfeeding plan pregnant within 7 month . 2 . Use investigational product nonregistered product ( drug vaccine ) within 30 day precede first dose study vaccine plan use study period . 3 . Received immunosuppressed , immunoregulation therapy corticosteroid systemic therapy 14 day 6 month entry , except local treatment . 4 . Administration immunoglobulin blood product within 3 month precede first dose study vaccine . 5 . Administration attenuate live vaccine within 30 day precede first dose study vaccine subunit inactivated vaccine within 14 day vaccination . 6 . Had fever ( axillary temperature 38°C ) within 3 day acute illness require systemic antibiotic antiviral treatment within 5 day vaccination . 7 . Having plan participate another clinical trial study period . 8 . Received another HPV vaccine . 9 . Immunodeficiency ( HIV carrier ) , primary disease important organ , malignant tumor , .or immune disease ( systemic lupus erythematosus , arthritis pauperum , splenectomy functional asplenia disease might affect immune response ) . 10 . History allergic disease history serious adverse event occur vaccination , i.e. , allergy , urticaria , dyspnea , angioneurotic edema abdominal pain . 11 . Having serious disease internal medicine , hypertension , cardiac disease , diabetes , hyperthyroidism et al . 12 . Asthma require emergent treatment , hospitalization , oral intravenous corticosteroid unstable condition within past 2 year . 13 . Diagnosed coagulant function abnormality ( i.e. , clot factor absent , clot hemorrhagic disease , abnormal platelet function ) blood coagulation disorder . 14 . Epilepsy , except fever epilepsy 2 year age , alcoholinduced epilepsy 3 year abstinence , idiopathic epilepsy require treatment past 3 year . 15 . Past current twostage affective psychosis , well control past 2 year require drug , h tendency commit suicide . 16 . Other medical , psychological , social occupational factor , accord investigator ' judgment , might affect individual 's ability obey protocol sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>human papillomavirus vaccine</keyword>
	<keyword>condylomata acuminata</keyword>
</DOC>